华人健康
(301408)
| 流通市值：18.03亿 | | | 总市值：48.36亿 |
| 流通股本：1.49亿 | | | 总股本：4.00亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,100,235,527.15 | 1,012,957,369.12 | 1,266,605,691.51 | 1,336,326,502.97 |
| 结算备付金 | 0 | 0 | 0 | 0 |
| 拆出资金 | 0 | 0 | 0 | 0 |
| 衍生金融资产 | 0 | 0 | 0 | 0 |
| 应收票据及应收账款 | 505,094,169 | 491,658,780.95 | 565,537,472.5 | 493,542,322.21 |
| 其中：应收票据 | 0 | 0 | 0 | 0 |
| 应收账款 | 505,094,169 | 491,658,780.95 | 565,537,472.5 | 493,542,322.21 |
| 应收款项融资 | 3,348,939.22 | 7,240,449.57 | 9,844,044.68 | 19,601,193.75 |
| 预付款项 | 125,320,384.58 | 108,566,935.76 | 121,391,737.09 | 137,321,625.28 |
| 应收保费 | 0 | 0 | 0 | 0 |
| 应收分保账款 | 0 | 0 | 0 | 0 |
| 应收分保合同准备金 | 0 | 0 | 0 | 0 |
| 其他应收款合计 | 53,625,385.4 | 43,842,205.5 | 59,255,708.31 | 36,236,200.82 |
| 其中:应收利息 | 0 | 0 | 0 | 0 |
| 应收股利 | 0 | 0 | 0 | 0 |
| 买入返售金融资产 | 0 | 0 | 0 | 0 |
| 存货 | 840,088,361.33 | 895,199,622.59 | 911,360,890.33 | 772,087,871.23 |
| 合同资产 | 0 | - | 0 | 0 |
| 一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
| 其他流动资产 | 18,647,243.9 | 23,825,467.71 | 22,093,036.44 | 18,733,210.79 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,741,460,398.28 | 2,583,290,831.2 | 2,963,808,764.97 | 2,826,254,957.65 |
| 非流动资产: | | | | |
| 债权投资 | 0 | - | 0 | 0 |
| 其他债权投资 | 0 | - | 0 | 0 |
| 长期应收款 | 0 | 0 | 0 | 0 |
| 长期股权投资 | 0 | 0 | 14,428,257.15 | 14,428,257.15 |
| 其他权益工具投资 | 82,197,162.37 | 97,213,666.38 | 82,879,209.82 | 78,379,209.82 |
| 其他非流动金融资产 | 0 | - | 0 | 0 |
| 投资性房地产 | 1,881,338.61 | 1,889,482.02 | 1,913,211.03 | 1,929,147.24 |
| 固定资产 | 316,193,949.38 | 326,998,085.15 | 333,334,307.55 | 330,258,514.21 |
| 在建工程 | 128,378,823.13 | 124,981,581.7 | 102,844,607.12 | 61,335,843.94 |
| 生产性生物资产 | 0 | 0 | 0 | 0 |
| 油气资产 | 0 | 0 | 0 | 0 |
| 使用权资产 | 520,006,999.06 | 499,780,915.19 | 473,175,768.53 | 478,551,565.2 |
| 无形资产 | 64,751,574.37 | 65,557,646.55 | 66,522,932.43 | 62,506,565.09 |
| 开发支出 | 0 | 0 | 0 | 0 |
| 商誉 | 993,657,468.46 | 874,437,027.79 | 769,168,633.52 | 609,312,977.19 |
| 长期待摊费用 | 58,073,797.41 | 56,950,526.77 | 56,207,063.29 | 52,106,611.6 |
| 递延所得税资产 | 42,357,433.68 | 39,048,292.61 | 40,226,234.42 | 32,827,464.23 |
| 其他非流动资产 | 12,000,000 | 40,882,752.19 | 33,354,100 | 63,806,806.33 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,219,498,546.47 | 2,127,739,976.35 | 1,974,054,324.86 | 1,785,442,962 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,960,958,944.75 | 4,711,030,807.55 | 4,937,863,089.83 | 4,611,697,919.65 |
| 流动负债: | | | | |
| 短期借款 | 377,000,000 | 252,341,402.56 | 312,740,945.28 | 513,512,092.5 |
| 向中央银行借款 | 0 | 0 | 0 | 0 |
| 吸收存款及同业存放 | 0 | 0 | 0 | 0 |
| 拆入资金 | 0 | 0 | 0 | 0 |
| 交易性金融负债 | 0 | - | 0 | 0 |
| 衍生金融负债 | 0 | 0 | 0 | 0 |
| 应付票据及应付账款 | 1,193,106,824.9 | 1,151,490,287.07 | 1,349,000,497.01 | 1,026,818,003.38 |
| 其中：应付票据 | 813,197,698.09 | 765,685,558.43 | 834,510,548.19 | 773,930,812.61 |
| 应付账款 | 379,909,126.81 | 385,804,728.64 | 514,489,948.82 | 252,887,190.77 |
| 预收款项 | 5,523,955.05 | 6,134,232.6 | 4,954,981.14 | 5,733,761.78 |
| 合同负债 | 42,261,015.35 | 35,063,006.26 | 39,211,528.01 | 21,329,077.31 |
| 卖出回购金融资产款 | 0 | 0 | 0 | 0 |
| 应付手续费及佣金 | 0 | 0 | 0 | 0 |
| 应付职工薪酬 | 47,789,245.52 | 44,287,250.72 | 45,717,962.61 | 43,861,712.56 |
| 应交税费 | 24,328,935.01 | 22,136,174.74 | 35,770,710.04 | 23,952,142.82 |
| 其他应付款合计 | 202,451,783 | 147,958,102.31 | 104,828,338.65 | 70,572,909.07 |
| 其中:应付利息 | 0 | 0 | 0 | 0 |
| 应付股利 | 7,681,037.39 | 0 | 0 | 0 |
| 应付分保账款 | 0 | 0 | 0 | 0 |
| 保险合同准备金 | 0 | 0 | 0 | 0 |
| 代理买卖证券款 | 0 | 0 | 0 | 0 |
| 代理承销证券款 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 269,816,005.3 | 393,199,047.64 | 249,554,799.12 | 255,389,025.24 |
| 其他流动负债 | 4,710,819.82 | 3,547,395.57 | 4,207,833.22 | 2,566,484.99 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,166,988,583.95 | 2,056,156,899.47 | 2,145,987,595.08 | 1,963,735,209.65 |
| 非流动负债: | | | | |
| 长期借款 | 422,878,450.33 | 295,614,535.98 | 431,209,518.32 | 331,152,444.44 |
| 应付债券 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 租赁负债 | 243,126,765.69 | 231,326,073.57 | 223,144,419.5 | 237,650,528.14 |
| 长期应付款 | 95,400,000 | 95,400,000 | 94,154,488.5 | 95,400,000 |
| 长期应付职工薪酬 | 0 | 0 | 0 | 0 |
| 预计负债 | 0 | 0 | 0 | 0 |
| 递延收益 | 831,693.26 | 857,153.27 | 908,073.29 | 908,073.29 |
| 递延所得税负债 | 6,758,327.88 | 6,920,108.29 | 7,179,044.63 | 6,321,546.84 |
| 其他非流动负债 | 0 | 0 | 0 | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 768,995,237.16 | 630,117,871.11 | 756,595,544.24 | 671,432,592.71 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,935,983,821.11 | 2,686,274,770.58 | 2,902,583,139.32 | 2,635,167,802.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 400,010,000 | 400,010,000 | 400,010,000 | 400,010,000 |
| 其他权益工具 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 资本公积 | 1,014,137,343.23 | 1,014,137,343.23 | 1,014,137,343.23 | 1,014,137,343.23 |
| 减:库存股 | 0 | 0 | 0 | 0 |
| 其他综合收益 | 0 | 0 | 0 | 0 |
| 专项储备 | 0 | 0 | 0 | 0 |
| 盈余公积 | 31,333,725.76 | 31,300,292.76 | 31,300,292.76 | 31,300,292.76 |
| 一般风险准备 | 0 | 0 | 0 | 0 |
| 未分配利润 | 530,038,919.03 | 531,054,329.35 | 545,857,792.09 | 498,085,491.05 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,975,519,988.02 | 1,976,501,965.34 | 1,991,305,428.08 | 1,943,533,127.04 |
| 少数股东权益 | 49,455,135.62 | 48,254,071.63 | 43,974,522.43 | 32,996,990.25 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,024,975,123.64 | 2,024,756,036.97 | 2,035,279,950.51 | 1,976,530,117.29 |
| 负债和股东权益合计 | 4,960,958,944.75 | 4,711,030,807.55 | 4,937,863,089.83 | 4,611,697,919.65 |
| 公告日期 | 2024-10-29 | 2024-08-29 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |